Ads
related to: novartis- Contact Us
Contact a PYLARIFY sales
representative to stay updated.
- Resources for PYLARIFY
Discover downloadable guides for
health care professionals.
- PYLARIFY Updates
Be among the first to receive new
imaging locations & news updates.
- PYLARIFY Imaging Sites
Find or register a PYLARIFY
imaging site.
- Contact Us
Search results
US judge orders probe of Novartis $30 mln settlement claims process
Reuters· 13 hours agoA federal judge has ordered a probe of the claims distribution process in a $30 million settlement...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via Yahoo News· 23 hours agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into...
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations - Novartis...
Benzinga· 13 hours agoItaly’s antitrust regulator has initiated an investigation into several pharmaceutical giants,...
Why Novartis (NVS) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 16 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Earnings call: Novartis outlines strong forecast for Scemblix in CML treatment
Investing.com· 2 days agoNovartis has projected robust sales for its new chronic myeloid leukemia (CML) treatment, Scemblix,...
Novartis, Roche, Biogen and Samsung Bioepis in Italy Eye-Medicine Probe
Morningstar· 20 hours agoItaly's competition watchdog is investigating four pharmaceutical companies over what it called coordination of their commercial strategies, allegedly delaying access to a biosimilar eye-disease ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 hours agoAt BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 7 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Novartis study points to larger role for targeted leukemia drug
BioPharma Dive via Yahoo Finance· 7 days agoThe results are from a late-stage clinical trial run by Scemblix’s maker, Novartis, and will be...
Novartis leukemia drug more effective than older treatments in trial
Reuters via AOL· 7 days agoSwiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a...